February 16, 2018 / 12:12 PM / 8 months ago

U.S. FDA declines to approve Apricus' erectile dysfunction cream

Feb 16 (Reuters) - Apricus Biosciences Inc said on Friday the U.S. Food and Drug Administration declined to approve Vitaros, a cream-based treatment for erectile dysfunction, in its present form.

The FDA flagged certain safety concerns related to an ingredient in the drug, which was first rejected by the regulator a decade ago. (Reporting by Tamara Mathias in Bengaluru; Editing by Savio D’Souza)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below